The PD-1/PD-L1 axis has been thoroughly investigated in the oncological setting, and these molecules seem to be upregulated in a variety of cancer cells (ovarian/gastric carcinoma/leukemia) [31,32,33]. This evidence concerns the gene PDCD1 and gastric carcinoma.